1. Home
  2. PCRX vs SVM Comparison

PCRX vs SVM Comparison

Compare PCRX & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • SVM
  • Stock Information
  • Founded
  • PCRX 2006
  • SVM N/A
  • Country
  • PCRX United States
  • SVM Canada
  • Employees
  • PCRX N/A
  • SVM N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • SVM Precious Metals
  • Sector
  • PCRX Health Care
  • SVM Basic Materials
  • Exchange
  • PCRX Nasdaq
  • SVM Nasdaq
  • Market Cap
  • PCRX 604.7M
  • SVM 663.6M
  • IPO Year
  • PCRX 2011
  • SVM N/A
  • Fundamental
  • Price
  • PCRX $22.84
  • SVM $3.16
  • Analyst Decision
  • PCRX Buy
  • SVM Strong Buy
  • Analyst Count
  • PCRX 10
  • SVM 1
  • Target Price
  • PCRX $27.60
  • SVM $5.10
  • AVG Volume (30 Days)
  • PCRX 787.3K
  • SVM 3.4M
  • Earning Date
  • PCRX 02-27-2025
  • SVM 02-11-2025
  • Dividend Yield
  • PCRX N/A
  • SVM 0.41%
  • EPS Growth
  • PCRX N/A
  • SVM 63.39
  • EPS
  • PCRX N/A
  • SVM 0.29
  • Revenue
  • PCRX $694,957,000.00
  • SVM $241,357,000.00
  • Revenue This Year
  • PCRX $4.83
  • SVM $31.86
  • Revenue Next Year
  • PCRX $2.16
  • SVM $10.34
  • P/E Ratio
  • PCRX N/A
  • SVM $10.73
  • Revenue Growth
  • PCRX 4.40
  • SVM 16.71
  • 52 Week Low
  • PCRX $11.16
  • SVM $2.22
  • 52 Week High
  • PCRX $34.01
  • SVM $5.32
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 72.97
  • SVM 50.46
  • Support Level
  • PCRX $18.18
  • SVM $2.98
  • Resistance Level
  • PCRX $22.36
  • SVM $3.27
  • Average True Range (ATR)
  • PCRX 1.17
  • SVM 0.14
  • MACD
  • PCRX 0.33
  • SVM 0.04
  • Stochastic Oscillator
  • PCRX 99.15
  • SVM 71.79

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral mining company. It acquires, explores, develops, and mines precious and base metal mineral properties at its producing mines and exploration and development projects in China. The group produces silver, gold, lead, and zinc. The company creates shareholder's value by focusing on generating free cash flow from long-life mines; organic growth through extensive drilling for discovery; equity investments in potential world-class opportunities; ongoing merger and acquisition efforts to unlock value; and long-term commitment to responsible mining and ESG. The Company's producing mines are located in China, and current exploration and development projects are located in China and Mexico.

Share on Social Networks: